Development of CRF1 Receptor Antagonists as Antidepressants and Anxiolytics: Progress to Date

ISSN： 1172-7047

Source： CNS Drugs, Vol.20, Iss.11, 2006-01, pp. : 887-896

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CRF Receptor Antagonists: Utility in Research and Clinical Practice

Current Medicinal Chemistry, Vol. 13, Iss. 23, 2006-10 ,pp. : 2751-2760

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro pharmacological profile of nonpeptide CRF 1 receptor antagonists, CRA1000 and CRA1001

By Chaki S. Okuyama S. Nakazato A. Kumagai T. Okubo T. Ikeda Y. Oshida Y. Hamajima Y. Tomisawa K.

European Journal of Pharmacology, Vol. 371, Iss. 2, 1999-04 ,pp. : 205-211

Elsevier

Access to resources Recommend Favorite

CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents

By Douma T. Millan M. Boulay D. Griebel G. Verdouw P. Westphal K. Olivier B. Groenink L.

Psychopharmacology, Vol. 231, Iss. 7, 2014-04 ,pp. : 1289-1303

Springer Publishing Company

Access to resources Recommend Favorite

Non-Peptidic CRF1 Receptor Antagonists for the Treatment of Anxiety,Depression and Stress Disorders

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 5, 2002-10 ,pp. : 467-493

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists

By Johansson Anders

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 6, 2011-06 ,pp. : 905-925

Informa Healthcare

Access to resources Recommend Favorite